Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
BPG | Ann: Blackpearl Group Q4 FY24 Results Announcement | 15/04/24 | 0 | 89 | |||
|
|||||||
BPG | Ann: BPG Revenue and Product Update | 08/04/24 | 14 | 1.3K | |||
|
|||||||
BPG | Ann: Blackpearl Group Q3 FY24 Results Announcement | 22/01/24 | 0 | 110 | |||
|
|||||||
BPG | Ann: D&O Disclosure Notice - Timothy Crown | 05/12/23 | 0 | 91 | |||
|
|||||||
BPG | Ann: D&O Disclosure Notice - Mark Osborne | 05/12/23 | 0 | 75 | |||
|
|||||||
BPG | Ann: D&O Disclosure Notice - Cherryl Pressley | 05/12/23 | 0 | 69 | |||
|
|||||||
BPG | Ann: Capital Change Notice | 04/12/23 | 0 | 83 | |||
|
|||||||
BPG | Ann: BPG Half Year Results | 01/12/23 | 1 | 382 | |||
|
See All Discussions